The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“extracts such as Curcuma xanthorrhiza, Fumaria officinalis, and various Ayurvedic formulations have not shown significant clinical benefit”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [86]
In the citing paper
“extracts such as Curcuma xanthorrhiza, Fumaria officinalis, and various Ayurvedic formulations have not shown significant clinical benefit”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [86]
In the citing paper
“In a randomized, double-blind, placebo-controlled trial, pain increased in the Curcuma xanthorriza group compared with placebo (p = 0.81), abdominal distension decreased more in the placebo group than in the treatment group, and the global assessment of IBS symptoms did not differ significantly between groups [86].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [86]
In the citing paper
“In a randomized, double blind, placebo-controlled trial, abdominal pain decreased more in the placebo group, abdominal distension decreased in the placebo group but increased in the Fumaria officinalis group (p = 0.48), and global assessment of IBS symptom changes and IBS-related psychological stress did not differ significantly among the two treatment groups [86].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [86]
In the citing paper
“another botanical species of the Curcuma genus, Curcuma xanthorriza (xanthorrhizol, curcuminoids, germacrone, sesquiterpenes) (Japanese turmeric), has not demonstrated therapeutic benefit over placebo.”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [86]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“IBS has a negative impact on patients’ daily activities and quality of life and incurs substantial health-care costs [3,4].”
Background
Research works printed but not linked: 30
- 10.1046/j.1365-2036.2003.01456.x · DOI
- Ehlin AG, 2003, Gut, 52, 1117, 10.1136/gut.52.8.1117 · DOI
- 10.7326/0003-4819-134-9_Part_2-200105011-00010 · DOI
- Maxwell PR, 1997, Lancet, 350, 1691, 10.1016/S0140-6736(97)05276-8 · DOI
- 10.1001/archinte.161.17.2081 · DOI
- Jones J, 2000, Gut, 47, 1, 10.1136/gut.47.suppl_2.ii1 · DOI
- Fennerty MB, 2003, Rev Gastroenterol Disord, 3, 18
- 10.1056/NEJMra035579 · DOI
- Jailwala J, 2000, Ann Intern Med, 133, 136, 10.7326/0003-4819-133-2-200007180-00013 · DOI · Paper page
- Talley NJ, 1996, Am J Gastroenterol, 91, 277
- Langmead L, 2002, Inflamm Bowel Dis, 8, 174, 10.1097/00054725-200205000-00003 · DOI
- Spanier JA, 2003, Arch Intern Med, 163, 265, 10.1001/archinte.163.3.265 · DOI
- Ramprasad C, 1957, J Scientif Industr Res, 16, 108
- Srimal RC, 1973, J Pharm Pharmacol, 25, 447, 10.1111/j.2042-7158.1973.tb09131.x · DOI · Paper page
- Baumann JC, 1971, Arzneimittelforschung, 21, 98
- Baumann JC, 1975, Med Monatsschr, 29, 173
- Gruenwald J, 2000, PDR for herbal medicines
- Cahen R, 1964, Therapie, 19, 357
- Pandey VB, 1971, Pugsley Curr Sci, 40, 455
- Giroux J, 1966, Therapie, 21, 889
- De Smet PA, 2002, N Engl J Med, 347, 2046, 10.1056/NEJMra020398 · DOI
- Beck AT, 1961, Arch Gen Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- Hautzinger M, 1995, Beck-Depressions-Inventar (BDI) Testhandbuch
- Fahrenberg J, 1994, Freiburger Persönlichkeitsinventar (FPI). Revidierte Fassung FPI-R und teilweise geänderte Fassung FPI-A1
- Drossman DA, 2000, Rome II: the functional gastrointestinal disorders2nd ed
- Klein KB, 1988, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8 · DOI
- Maiwald L, 1985, Z Allgemeinmedizin, 61, 1272
- Roux M, 1978, Gaz Méd de France, 84, 3794
- Sood GK, 1993, Am J Gastroenterol, 88, 1387
- Zacharewicz M, 1979, Wien Med Wochenschr, 129, 221
Cited by
Serra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
Dorn, S. D., Kaptchuk, T. J., Park, J. B., Nguyen, L. T., Canenguez, K., Nam, B. H., Woods, K. B., Conboy, L. A., Stason, W. B., & Lembo, A. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00937.x · Cited by 119
A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)
Ng, Q., Soh, A., Loke, W., Venkatanarayanan, N., Lim, D., & Yeo, W.-S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100298 · Cited by 95
A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders
Thavorn, K., Wolfe, D., Faust, L., Shorr, R., Akkawi, M., Isaranuwatchai, W., Klinger, C., Chai‐Adisaksopa, C., Tanvejsilp, P., Nochaiwong, S., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8189 · Cited by 11
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1
Metadata
- Authors
- Brinkhaus, B., Hentschel, C., Keudell, C. V., Schindler, G., Lindner, M., Stützer, H., Kohnen, R., Willich, S. N., Lehmacher, W., & Hahn, E. G. G.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 40
- Issue
- 8
- Pages
- 936-943
- ISSN
- 0036-5521
- 1502-7708
- Cited by
- 50
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
